======= CISH ======= == Gene Information == * **Official Symbol**: CISH * **Official Name**: cytokine inducible SH2 containing protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1154|1154]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NSE2|Q9NSE2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CISH&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CISH|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602441|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene contains a SH2 domain and a SOCS box domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein has been shown to be involved in the inactivation of the erythropoietin receptor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]. * **UniProt Summary**: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. CIS is involved in the negative regulation of cytokines that signal through the JAK-STAT5 pathway such as erythropoietin, prolactin and interleukin 3 (IL3) receptor. Inhibits STAT5 trans-activation by suppressing its tyrosine phosphorylation. May be a substrate- recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). {ECO:0000250}. |SH2| |SOCS box| |1-phosphatidylinositol-3-kinase regulator activity| |interleukin-7-mediated signaling pathway| |phosphatidylinositol 3-kinase complex| |protein kinase C-activating G protein-coupled receptor signaling pathway| |cellular response to interleukin-7| |response to interleukin-7| |negative regulation of insulin receptor signaling pathway| |negative regulation of cellular response to insulin stimulus| |phosphatidylinositol phosphorylation| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |regulation of insulin receptor signaling pathway| |lipid phosphorylation| |regulation of cellular response to insulin stimulus| |regulation of phospholipid metabolic process| |phosphatidylinositol metabolic process| |lipid modification| |glycerophospholipid metabolic process| |post-translational protein modification| |phospholipid metabolic process| |glycerolipid metabolic process| |regulation of lipid metabolic process| |regulation of cell growth| |cellular component| |regulation of growth| |cytokine-mediated signaling pathway| |protein ubiquitination| |molecular function| |protein modification by small protein conjugation| |regulation of kinase activity| |organophosphate metabolic process| |cellular lipid metabolic process| |regulation of transferase activity| |protein modification by small protein conjugation or removal| |cellular response to cytokine stimulus| |response to cytokine| |lipid metabolic process| |negative regulation of signal transduction| |phosphorylation| |G protein-coupled receptor signaling pathway| |negative regulation of cell communication| |negative regulation of signaling| |regulation of phosphorylation| |negative regulation of response to stimulus| |intracellular signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.07| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6716 * **Expression level (log2 read counts)**: 2.46 {{:chemogenomics:nalm6 dist.png?nolink |}}